[Arg6,D-Trp7,9,NmePhe8]-substance P (6–11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
1999
New Anti-Cancer Agent Shows Promise for Lung Cancer
publication
Evidence: moderate
Author Information
Author(s): MacKinnon A C, Armstrong R A, Waters C M, Cummings J, Smyth J F, Haslett C, Sethi T
Primary Institution: University of Edinburgh Medical School
Hypothesis
Does antagonist G induce apoptosis in small cell lung cancer cells through an oxidant-dependent mechanism?
Conclusion
Antagonist G stimulates apoptosis and activates JNK in small cell lung cancer cells, potentially aiding in cancer treatment.
Supporting Evidence
- Antagonist G inhibits small-cell lung cancer cell growth in vitro and in vivo.
- The drug stimulates apoptosis in cancer cells.
- Antagonist G activates JNK activity in small cell lung cancer cells.
- The mechanism of action involves the generation of reactive oxygen species.
Takeaway
A new drug called antagonist G helps kill lung cancer cells and works in a special way that might help treat cancer better.
Methodology
The study assessed the effects of antagonist G on small cell lung cancer cell lines in vitro and in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website